Clover Health Investments (NASDAQ:CLOV) Price Target Increased to $3.50 by Analysts at Citigroup

Clover Health Investments (NASDAQ:CLOVGet Rating) had its price objective raised by Citigroup to $3.50 in a research note issued to investors on Monday morning, Stock Target Advisor reports.

Separately, Credit Suisse Group lowered their target price on Clover Health Investments from $3.50 to $3.00 and set an underperform rating on the stock in a report on Tuesday, August 9th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of Hold and a consensus target price of $4.17.

Clover Health Investments Stock Down 1.5 %

Shares of Clover Health Investments stock opened at $3.25 on Monday. The stock’s 50 day simple moving average is $2.57 and its 200-day simple moving average is $2.74. Clover Health Investments has a 1-year low of $1.95 and a 1-year high of $11.13. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.16 and a current ratio of 1.16.

Institutional Trading of Clover Health Investments

Institutional investors have recently made changes to their positions in the company. Sterling Investment Advisors Ltd. raised its position in shares of Clover Health Investments by 65,000.0% during the 2nd quarter. Sterling Investment Advisors Ltd. now owns 13,020 shares of the company’s stock valued at $28,000 after buying an additional 13,000 shares during the period. Lazard Asset Management LLC purchased a new stake in Clover Health Investments in the first quarter valued at approximately $35,000. Nicholas Hoffman & Company LLC. purchased a new stake in Clover Health Investments in the first quarter valued at approximately $36,000. Atria Wealth Solutions Inc. purchased a new stake in Clover Health Investments in the first quarter valued at approximately $36,000. Finally, Independent Wealth Network Inc. purchased a new stake in Clover Health Investments in the first quarter valued at approximately $37,000. Hedge funds and other institutional investors own 23.26% of the company’s stock.

Clover Health Investments Company Profile

(Get Rating)

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses.

Read More



Receive News & Ratings for Clover Health Investments Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Clover Health Investments and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *